CVS Caremark, Chief Scientific Officer and Chief Medical Officer, Provider Innovation
Dr. William Shrank is Chief Scientific Officer and Chief Medical Officer, Provider Innovation for CVS Caremark. In this role, Dr. Shrank focuses on the development of innovative pharmacy solutions to help improve the quality of care, while lowering costs, in order to help health care providers deliver services to distinct patient populations. Dr. Shrank also oversees the company’s overall research agenda and evaluation of clinical program development with the goal of strengthening rapid learning capabilities.
Dr. Shrank has extensive experience in pharmaceutical outcomes research and has published extensively on topics including the evaluation of progressive pharmacy benefit designs, the Medicare Part D Prescription Drug benefit, medication adherence for chronic conditions and ensuring high-quality patient communications regarding the risks and benefits of prescribed medications.
Prior to joining CVS Caremark, Dr. Shrank was a practicing physician with Brigham Internal Medicine Associates at Brigham and Women’s Hospital in Boston, and Faculty at Harvard Medical School in the Division of Pharmacoepidemiology and Pharmacoeconomics. Previously Dr. Shrank served as Director, Research and Rapid-Cycle Evaluation for the Center for Medicare & Medicaid Innovation at the Centers for Medicare & Medicaid Services (CMS) where he participated in the design of and developed the evaluation strategy for new federal payment models initiated under the Affordable Care Act.
Dr. Shrank received his Medical Degree from Cornell University Medical College, his Masters of Science degree in Health Services from the University of California at Los Angeles and his Bachelor’s Degree from Brown University.